Evidence mapPaperPMID 39747798Full record

ReviewCurrent topics in behavioral neurosciences2026

Chemical Probes for Investigating the Endocannabinoid System.

Annaleah Hanske, Marc Nazaré, Uwe Grether

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current topics in behavioral neurosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. ChemBioParis 2025: Approaching Biology Through Chemistry in the City of Light.Chembiochem : a European journal of chemical biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Annaleah HanskeLeibniz-Forschungsinstitut für Molekulare Pharmakologie FMP, Berlin, Germany.
Marc NazaréLeibniz-Forschungsinstitut für Molekulare Pharmakologie FMP, Berlin, Germany.
Uwe GretherPharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland. uwe.grether@roche.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cannabis sativa has been used therapeutically since early civilizations, with key cannabinoids Δ

Indexed as

EndocannabinoidsReceptors, CannabinoidAnimalsHumansEndocannabinoidsReceptors, Cannabinoid2-Arachidonoylglycerol (2-AG)Cannabinoid receptor type-1 (CB1R)Cannabinoid receptor type-2 (CB2R)Chemical probesDiacylglycerol lipase (DAGL)Endocannabinoid system (ECS)Fatty acid amide hydrolase (FAAH)Fatty acid-binding protein (FABP)Monoacylglycerol lipase (MAGL)N-Acylethanolamine acid amidase (NAAA)N-Acylphosphatidylethanolamine-specific phospholipase D (NAPE-PLD)N-Arachidonoylethanolamine (AEA)Reverse-design

Identifiers

PMID39747798

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.